Logo image of NKLA

NIKOLA CORP (NKLA) Stock Fundamental Analysis

NASDAQ:NKLA - Nasdaq - US6541103031 - Common Stock - Currency: USD

0.183  -0.07 (-28.74%)

After market: 0.1859 +0 (+1.58%)

Fundamental Rating

2

Overall NKLA gets a fundamental rating of 2 out of 10. We evaluated NKLA against 128 industry peers in the Machinery industry. NKLA has a bad profitability rating. Also its financial health evaluation is rather negative. NKLA is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year NKLA has reported negative net income.
NKLA had a negative operating cash flow in the past year.
NKLA had negative earnings in 4 of the past 5 years.
In the past 5 years NKLA always reported negative operating cash flow.
NKLA Yearly Net Income VS EBIT VS OCF VS FCFNKLA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 -200M -400M -600M -800M

1.2 Ratios

NKLA's Return On Assets of -61.27% is on the low side compared to the rest of the industry. NKLA is outperformed by 92.13% of its industry peers.
Looking at the Return On Equity, with a value of -167.38%, NKLA is doing worse than 89.76% of the companies in the same industry.
Industry RankSector Rank
ROA -61.27%
ROE -167.38%
ROIC N/A
ROA(3y)-69.66%
ROA(5y)-48.86%
ROE(3y)-127.62%
ROE(5y)-84.19%
ROIC(3y)N/A
ROIC(5y)N/A
NKLA Yearly ROA, ROE, ROICNKLA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 -50 -100

1.3 Margins

NKLA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NKLA Yearly Profit, Operating, Gross MarginsNKLA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 -100K -200K -300K -400K

1

2. Health

2.1 Basic Checks

NKLA does not have a ROIC to compare to the WACC, probably because it is not profitable.
NKLA has more shares outstanding than it did 1 year ago.
NKLA has more shares outstanding than it did 5 years ago.
NKLA has a better debt/assets ratio than last year.
NKLA Yearly Shares OutstandingNKLA Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
NKLA Yearly Total Debt VS Total AssetsNKLA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of -6.37, we must say that NKLA is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of NKLA (-6.37) is worse than 88.19% of its industry peers.
NKLA has a Debt/Equity ratio of 0.72. This is a neutral value indicating NKLA is somewhat dependend on debt financing.
NKLA has a worse Debt to Equity ratio (0.72) than 70.87% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF N/A
Altman-Z -6.37
ROIC/WACCN/A
WACC2.73%
NKLA Yearly LT Debt VS Equity VS FCFNKLA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 500M -500M

2.3 Liquidity

NKLA has a Current Ratio of 1.17. This is a normal value and indicates that NKLA is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.17, NKLA is doing worse than 87.40% of the companies in the same industry.
NKLA has a Quick Ratio of 1.17. This is a bad value and indicates that NKLA is not financially healthy enough and could expect problems in meeting its short term obligations.
NKLA's Quick ratio of 0.94 is on the low side compared to the rest of the industry. NKLA is outperformed by 70.08% of its industry peers.
Industry RankSector Rank
Current Ratio 1.17
Quick Ratio 0.94
NKLA Yearly Current Assets VS Current LiabilitesNKLA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M

7

3. Growth

3.1 Past

NKLA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 66.31%, which is quite impressive.
Looking at the last year, NKLA shows a very strong growth in Revenue. The Revenue has grown by 153.71%.
NKLA shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 622.57% yearly.
EPS 1Y (TTM)66.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%69.44%
Revenue 1Y (TTM)153.71%
Revenue growth 3Y622.57%
Revenue growth 5YN/A
Sales Q2Q%1553.87%

3.2 Future

NKLA is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.89% yearly.
Based on estimates for the next years, NKLA will show a very strong growth in Revenue. The Revenue will grow by 129.36% on average per year.
EPS Next Y59.84%
EPS Next 2Y31.61%
EPS Next 3Y21.07%
EPS Next 5Y14.89%
Revenue Next Year177.15%
Revenue Next 2Y202.57%
Revenue Next 3Y139.21%
Revenue Next 5Y129.36%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
NKLA Yearly Revenue VS EstimatesNKLA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1B 2B 3B 4B 5B
NKLA Yearly EPS VS EstimatesNKLA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -10 -20 -30

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NKLA. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NKLA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NKLA Price Earnings VS Forward Price EarningsNKLA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NKLA Per share dataNKLA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10

4.3 Compensation for Growth

A more expensive valuation may be justified as NKLA's earnings are expected to grow with 21.07% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y31.61%
EPS Next 3Y21.07%

0

5. Dividend

5.1 Amount

NKLA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

NIKOLA CORP

NASDAQ:NKLA (2/25/2025, 8:00:01 PM)

After market: 0.1859 +0 (+1.58%)

0.183

-0.07 (-28.74%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)02-20 2025-02-20/amc
Earnings (Next)05-05 2025-05-05/amc
Inst Owners41.32%
Inst Owner Change0%
Ins Owners0.67%
Ins Owner Change0%
Market Cap15.46M
Analysts43.33
Price Target4.08 (2129.51%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-6.26%
Min EPS beat(2)-20.58%
Max EPS beat(2)8.05%
EPS beat(4)3
Avg EPS beat(4)3.35%
Min EPS beat(4)-20.58%
Max EPS beat(4)17.04%
EPS beat(8)6
Avg EPS beat(8)-8.62%
EPS beat(12)10
Avg EPS beat(12)2.34%
EPS beat(16)14
Avg EPS beat(16)10.04%
Revenue beat(2)1
Avg Revenue beat(2)-10.23%
Min Revenue beat(2)-33.69%
Max Revenue beat(2)13.22%
Revenue beat(4)1
Avg Revenue beat(4)-21.12%
Min Revenue beat(4)-53.46%
Max Revenue beat(4)13.22%
Revenue beat(8)1
Avg Revenue beat(8)-37.59%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-27.27%
EPS NQ rev (1m)-30.46%
EPS NQ rev (3m)-10.59%
EPS NY rev (1m)0%
EPS NY rev (3m)9.31%
Revenue NQ rev (1m)9.46%
Revenue NQ rev (3m)5.84%
Revenue NY rev (1m)-3.9%
Revenue NY rev (3m)-3.85%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.2
P/FCF N/A
P/OCF N/A
P/B 0.04
P/tB 0.05
EV/EBITDA N/A
EPS(TTM)-11.42
EYN/A
EPS(NY)-6.99
Fwd EYN/A
FCF(TTM)-6.79
FCFYN/A
OCF(TTM)-6.12
OCFYN/A
SpS0.89
BVpS4.49
TBVpS3.87
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -61.27%
ROE -167.38%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-69.66%
ROA(5y)-48.86%
ROE(3y)-127.62%
ROE(5y)-84.19%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 137.76%
Cap/Sales 73.94%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.17
Quick Ratio 0.94
Altman-Z -6.37
F-Score4
WACC2.73%
ROIC/WACCN/A
Cap/Depr(3y)1084.29%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)66.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%69.44%
EPS Next Y59.84%
EPS Next 2Y31.61%
EPS Next 3Y21.07%
EPS Next 5Y14.89%
Revenue 1Y (TTM)153.71%
Revenue growth 3Y622.57%
Revenue growth 5YN/A
Sales Q2Q%1553.87%
Revenue Next Year177.15%
Revenue Next 2Y202.57%
Revenue Next 3Y139.21%
Revenue Next 5Y129.36%
EBIT growth 1Y17.41%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year26.66%
EBIT Next 3Y19.66%
EBIT Next 5Y25.05%
FCF growth 1Y21.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y4.78%
OCF growth 3YN/A
OCF growth 5YN/A